By the time Pfizer Inc., Johnson and Johnson, Elan Corp. and Eli Lilly & Co. announced their experimental medicines had shown limited benefit for Alzheimer’s patients in late-stage testing, the industry and academia had spent more than $30 billion researching amyloid plaque in the brain. Now they are working together to prevent such failures.
Don Berwick’s admiration of the U.K. National Health Service didn’t help him among U.S. Senate Republicans when President Barack Obama needed someone to revamp the Medicare health insurance program three years ago. It didn’t hurt him this year when U.K. Prime Minister David Cameron needed someone to recommend remedies for the NHS.
Tougher restrictions on cosmetic procedures are needed in the U.K. after at least 490 women had their breast implants removed because of a manufacturing scandal in France, an advisory panel told the government.